Caspase-12 activation is involved in amyloid-β protein-induced synaptic toxicity

Journal of Alzheimer's Disease

Volumn 26, Issue 3, 2011, Pages 467-476

  Quiroz Baez, Ricardo ^a,b   Ferrera, Patricia ^b   Rosendo Gutiérrez, Rigoberto ^b   Morán, Julio ^b   Bermúdez Rattoni, Federico ^b   Arias, Clorinda ^b  

^a INSTITUTO NACIONAL DE GERIATRÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

3xTg AD; amyloid protein; caspase 12; endoplasmic reticulum; isolated nerve endings; synaptic apoptosis

Indexed keywords

ACTIN; AMYLOID BETA PROTEIN; CASPASE 12; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE ENDING; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE; SYNAPTIC DYSFUNCTION; SYNAPTOSOME; TRANSGENIC MOUSE;

EID: 80053489240     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110326     Document Type: Article

References (50)

1. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27, 457-464.
2. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
3. DeKosky ST, Scheff SW, Styren SD (1996) Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5, 417-421.
4. Coleman PD, Yao PJ (2003) Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 24, 1023-1027.
5. Counts SE, Nadeem M, Lad SP, Wuu J, Mufson EJ (2006) Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J Neuropathol Exp Neurol 65, 592-601.
6. Cole GM, Yang F, Chen PP, Frautschy SA, Hsiao K (1999) Caspase activation in dystrophic neurites in Alzheimer's disease and aged HuAPPsw transgenic mice. In Alzheimer's disease and related disorders: etiology, pathogenesis, and therapeutics. Iqbal K, Swaab DF, Winbland B, Wisniewski HM, eds. Wiley & Sons, New York, pp. 363-369.
7. Spires TL,Meyer-Luehmann M, Stern EA,McLean PJ, Skoch J, Nguyen PT, Bacskai BJ, Hyman BT (2005) Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci 25, 7278-7287.
8. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, Bloom FE (2006) Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 103, 5161-5166.
9. Klein WL, Krafft GA, Finch CE (2001) Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?. Trends Neurosci 24, 219-224.
10. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
11. Noguchi A, Matsumura S, Dezawa M, Tada M, Yanazawa M, Ito A, Akioka M, Kikuchi S, Sato M, Ideno S, Noda M, Fukunari A, Muramatsu S, Itokazu Y, Sato K, Takahashi H, Teplow DB, Nabeshima Y, Kakita A, Imahori K, Hoshi M (2009) Isolation and characterization of patient-derived, toxic, high mass amyloidβprotein (Aβ) assembly from Alzheimer disease brains. J Biol Chem 284, 32895-32905.
12. Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K, Morgan D (1999) Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet 29, 177-185.
13. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 96, 3228-3233.
14. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L (2000) High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20, 4050-4058.
15. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39, 409-421.
16. 2+- dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci U S A 100, 9572-9577.
17. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, LambertMP,Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL (2004) Synaptic targeting by Alzheimer's-related amyloidβ oligomers. J Neurosci 24, 10191-10200.
18. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14,837-842.
19. Mungarro-Menchaca X, Ferrera P, Morán J, Arias C (2002)β-Amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine. J Neurosci Res 68, 89-96.
20. Parodi J, Sepúlveda FJ, Roa J, Opazo C, Inestrosa NC, Aguayo LG (2010)βamyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 285, 2506-2514
21. Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW, Morris JC (2001) Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 56, 127-129.
22. Rossiter JP, Anderson LL, Yang F, Cole GM (2000) Caspasecleaved actin (fractin) immunolabelling of Hirano bodies. Neuropathol Appl Neurobiol 26, 342-346.
23. Zhao L, Ma QL, Calon F, Harris-White ME, Yang F, Lim GP, Morihara T, Ubeda OJ, Ambegaokar S, Hansen JE, Weisbart RH, Teter B, Frautschy SA, Cole GM (2006) Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat Neurosci 9, 234-242.
24. Lacor PN, Buniel MC, FurlowPW, Clemente AS,Velasco PT, Wood M, Viola KL, Klein WL (2007) Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27, 796-807.
25. WalshDM,Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181-193.
26. MattsonMP,Keller JN, Begley JG(1998) Evidence for synaptic apoptosis. Exp Neurol 153, 35-48.
27. Mattson MP, Partin J, Begley JG (1998) Amyloidβpeptide induces apoptosis-related events in synapses and dendrites. Brain Res 807, 167-176.
28. 2+ signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 23, 222-229.
29. 2+ homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59, 214-225
30. Stutzmann GE, Smith I, Caccamo A, Oddo S, Parker I, Laferla F (2007) Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models. Ann N Y Acad Sci 1097, 265-277.
31. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J (2000) Caspase-12 mediates endoplasmic-reticulumspecific apoptosis and cytotoxicity by amyloid-β. Nature 403, 98-103.
32. Löscher W, Bohme G, Muller F, Pagliusi S (1985) Improved method for isolating synaptosomes from 11 regions of one rat brain: electron microscopic and biochemical characterization and use in the study of drug effects on nerve terminal gammaaminobutyric acid in vivo. J Neurochem 45, 879-889.
33. Mossman T (1983) Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity. J Immunol Methods 65, 55-63.
34. 2+ release channel of sarcoplasmic reticulum. J Biol Chem 261, 6300-6306.
35. Ferreiro E, Resende R, Costa R, Oliveira CR, Pereira CM (2006) An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-β peptides neurotoxicity. Neurobiol Dis 23, 669-678.
36. Kaufman RJ (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13, 1211-1233.
37. Lindholm D, Wootz H, Korhonen L (2006) ER stress and neurodegenerative diseases. Cell Death Differ 13, 385-392.
38. Padua RA, Nagy JI, Geiger JD (1996) Subcellular localization of ryanodine receptors in rat brain. Eur J Pharmacol 298,185-189.
39. 2+ at presynaptic nerve terminals. FASEB 39, 2796-2801.
40. 2+ homeostasis and activation of calpains and caspase-12. Neurobiol Dis 11, 2-19.
41. Mashima T, Naito M, Fujita N, Noguchi K, Tsuruo T (1995) Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem Biophys Res Commun 217, 1185-1192.
42. Toh BH, Gallichio HA, Jeffrey PL, Livett BG, Muller HK, Cauchi MN, Clarke FM (1976) Anti-actin stain synapsis. Nature 264, 648-650.
43. Fischer U, Koenig L, Eckhart, Tschachler E (2002) Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun 293, 722-726.
44. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, Manabe T, Yamagishi S, Bando Y, Imaizumi K, Tsujimoto Y, Tohyama M (2004) Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ induced cell death. J Cell Biol 165, 347-356.
45. Oda T, Kosuge Y, Arakawa M, Ishige K, Ito Y (2008) Distinct mechanism of cell death is responsible for tunicamycininduced ER stress in SK-N-SH and SH-SY5Y cells. Neurosci Res 60, 29-39.
46. Yukioka F, Matsuzaki S, Kawamoto K, Koyama Y, Hitomi J, Katayama T, Tohyama M (2008) Presenilin-1 mutation activates the signaling pathway of caspase-4 in endoplasmic reticulum stress-induced apoptosis. Neurochem Int 52, 683-687.
47. Li Z, Jo J, Jia JM, Lo SC, Whitcomb DJ, Jiao S, Cho K, Sheng M (2010) Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 141, 859-871.
48. Hyman BT (2011) Caspase activation without apoptosis: insight into Aβ initiation of neurodegeneration. Nat Neurosci 14, 5-6.
49. D'Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A, Diamantini A, De Zio D, Carrara P, Battistini L, Moreno S, Bacci A, Ammassari-Teule M, Marie H, Cecconi F (2011) Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci 14, 69-76.
50. Louneva N, Cohen JW, Han LY, Talbot K,Wilson RS, Bennett DA, Trojanowski JQ, Arnold SE (2008) Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease. Am J Pathol 173, 1488-1495.